AcquisitionsApr 28, 2026, 04:10 PM
ONCO Proposes Realbotix Share Exchange; Registers 25M Shares for ELOC
AI Summary
Onconetix, Inc. (ONCO) filed an S-1 registering up to 25,000,000 shares for resale by Keystone Partners, LLC under an equity line of credit (ELOC), through which ONCO may receive up to $25.0 million. The company also announced a proposed Share Exchange Agreement to acquire Realbotix Corp., which would result in Realbotix's seller owning 75-90% of ONCO's fully diluted shares, subject to conditions including ONCO having at least $12.5 million Net Cash. These developments follow a one-for-five reverse stock split in March 2026 and recent management changes, as the company continues to face substantial doubt about its ability to continue as a going concern.
Key Highlights
- ONCO entered a Share Exchange Agreement to acquire Realbotix Corp.
- Realbotix's seller to own 75-90% of ONCO's fully diluted shares post-closing.
- Closing of Realbotix deal conditional on ONCO having at least $12.5 million Net Cash.
- ONCO registered up to 25,000,000 shares for resale by Keystone under an ELOC.
- ONCO may receive up to $25.0 million from Keystone under the ELOC.
- ONCO sold 701,933 shares for $8.1 million under ELOC through April 24, 2026.
- Company effected a one-for-five (1:5) reverse stock split on March 25, 2026.
- Cash balance was $4.2 million as of April 24, 2026; accumulated deficit $131.2 million.
- Two directors resigned; Sammy Dorf appointed Chairman; Josh Epstein elected to Board.